Letter | Published:

Increase in Specific Bactericidal Antibodies after Administration of Endotoxin

Naturevolume 191pages296297 (1961) | Download Citation

Subjects

Abstract

MANY non-specific immune phenomena have been described in which animals became resistant to experimental infection following administration of antigeni-cally unrelated materials. None has attracted more interest than the temporary state of enhanced resistance to infection with Gram-negative bacteria which develops in mice within hours after administration of antigenically unrelated bacterial endotoxins1. Among the many effects of endotoxins on the host is increased activity of the reticulo-endothelial system as shown by carbon clearance2 and by removal of phosphorus-32 labelled endotoxin3 or bacteria4. In addition, changes in the serum of endotoxin-treated animals have been reported, notably increased levels of properdin5, bactericidins6 and opsonins7,8. Passive transfer of opsonic capacity has also been demonstrated4. It is evident that these alterations in the host, individually or collectively, may contribute significantly to survival. Special emphasis has been placed on the nonspecific nature of the humoral factors involved, because there has been abundant confirmation of activity against bacterial strains antigenically unrelated to the endotoxin used for stimulation. Cross-reacting antibodies9 or a common antigen associated with the lipid complex of endotoxins10 have therefore been suggested to account for these observations.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Shilo, M., Ann. Rev. Microbiol., 13, 255 (1959).

  2. 2

    Biozzi, G., Benacerraf, B., and Halpern, B. N., Brit. J. Exp. Path., 36, 226 (1955).

  3. 3

    Howard, J. G., Rowley, D., and Wardlaw, A. C., Immunol., 1, 181 (1958).

  4. 4

    Benacerraf, B., Sebestyen, M. M., and Schlossman, S., J. Exp. Med., 110, 27 (1959).

  5. 5

    Landy, M., and Pillemer, L., J. Exp. Med., 103, 823 (1956).

  6. 6

    Rowley, D., Brit. J. Exp. Path., 37, 223 (1956).

  7. 7

    Rowley, D., J. Exp. Med., 111, 137 (1960).

  8. 8

    Jenkin, C. R., and Palmer, D. L., J. Exp. Med. 112, 419 (1960).

  9. 9

    Lee, L., and Stetson, C. A., J. Exp. Med., 111, 761 (1960).

  10. 10

    Benacerraf, B., and Miescher, P., Ann. N.Y. Acad. Sci., 88, 184 (1960).

  11. 11

    Landy, M., Michael, J. G., and Whitby, J. L. (in preparation).

Download references

Author information

Affiliations

  1. Laboratory of Chemical Pharmacology, National Cancer Institute, Bethesda, 14, Maryland

    • J. GABRIEL MICHAEL
    • , JAMES L. WHITBY
    •  & MAURICE LANDY

Authors

  1. Search for J. GABRIEL MICHAEL in:

  2. Search for JAMES L. WHITBY in:

  3. Search for MAURICE LANDY in:

About this article

Publication history

Issue Date

DOI

https://doi.org/10.1038/191296a0

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.